Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism()

Tight control of glucose excursions has been a long-standing goal of treatment for patients with type 2 diabetes mellitus in order to ameliorate the morbidity and mortality associated with hyperglycemia. Fibroblast growth factor (FGF) 19 is a hormone-like enterokine released postprandially that emer...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Marcelin, Geneviève, Jo, Young-Hwan, Li, Xiaosong, Schwartz, Gary J., Zhang, Ying, Dun, Nae J., Lyu, Rong-Ming, Blouet, Clémence, Chang, Jaw K., Chua, Streamson
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2013
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3929918/
https://ncbi.nlm.nih.gov/pubmed/24567901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2013.10.002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items